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Introduction 
 
Congenital hypothyroidism (CH) is an endocrine disease that is characterized by disturbances in 
thyroid function and changes in psychomotor development. High concentrations of hTSH (thyroid 
stimulating hormone) in the newborns blood are the first manifestation of CH, being this used for 
Newborn Screening (NBS) proposes.  
 
In newborns of low birth weight (<1500 g), in particular, those born prematurely (<30 weeks), is 
advised that NBS should be repeated, in a new sample collected two weeks after birth.  
Results from the revaluation of newborns whose immaturity of the hypothalamic-pituitary-thyroid 
could mask CH, leading to false negative results.  
 
hTSH is analyzed in all NBS and hTSH and T4 (tiroxine) for confirmation of elevated values. 
Between 2009 and 2010 the strategy for CH NBS was based only on hTSH evaluation, with a cut-   
  off of 20.0 µU/mL. Only in 2011 the hTSH cut-off is 10.0 µU/mL. 
 
 
 
 
 
-Since 2009-2011 
 
-302,511 newborns screened  on  
blood samples on filter paper using 
AutoDELFIA® Neonatal hTSH method 
 
-15,261 premature babies were 
analyzed 
Results 
 
 
Results and discussion 
 
During this period a total of 15,261 premature newborns were analyzed, and from these a 
second sample was received in only 1,149 suspected premature babies. This screening 
approach, allowed the detection of nine premature newborns with CH that would be missed 
if the screening was based only in the initial NBS sample. The treatment was started in 
these patients and are been evaluated. 
 
This study highlights the importance of sending the second sample in every preterm 
newborns, to decrease false negative results. Children not treated early are affected in 
varying degrees of mental and growth retardation, deafness and other serious metabolic 
symptoms. 
  
Methods 
Sample  
Weight 
(g)  
 
Screening  
1st 
Confirmation  
2nd 
Confirmation  
TSH   TSH  T4 TSH T4 
(µU/mL)  (µU/mL)  (µg/dL)  (µU/mL) (µg/dL)  
1 (2009)  727 11.2 56.1 <1.5 ― ― 
2 (2009)  1420 18.9 85.5 7.1 ― ― 
3 (2009)  575 10.4 6.0 3.4 10.3 3.5 
4 (2010)  688 6.9 10.2 4.9 236.9 3.0 
5 (2010)  906 6.5 1.6 5.7 1.4 5.7 
6 (2010)  1865 7.2 47.3 2.0 ― ― 
7(2011)  767 1.36 15.2 4.8 1.5 5.1 
8 (2011)  1200 4.1 21.3 4.6 48.1 5.7 
9 (2011)  574 3.0 14.2 5.9 3.9 6.7 
 
Normal values: 
hTSH <20.0 µU/mL (2009-2010) 
 
hTSH <10.0 µU/mL (2011)  
 
T4 (6.5-17.0) µg/dL   
 
